arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2601.17138q-bio.BM
收藏

人工智能在T细胞和B细胞受体建模及治疗设计中的发展

AI Developments for T and B Cell Receptor Modeling and Therapeutic Design

Yale School of Medicine(耶鲁大学医学院);Zürich University of Applied Sciences (ZHAW)(苏黎世应用科学大学)

Linhui Xie, Aurelien Pelissier, Yanjun Shao, Maria Rodriguez Martinez

AI总结:

本研究利用人工智能技术,通过预测和生成框架改进T和B细胞受体建模,提升治疗设计的效率和临床相关性。

摘要:

人工智能(AI)通过基于序列数据和免疫环境的预测和生成框架,加速了T细胞和B细胞受体建模的进展。本章回顾了蛋白质语言模型、机器学习和多模态整合在免疫受体建模中的最新进展。我们强调了利用单细胞和谱系级数据集的新兴策略,并优化免疫受体候选者以用于治疗设计。这些发展指向了一代更高效、通用且临床相关的新模型,能够更好地捕捉适应性免疫的多样性和复杂性。

英文摘要:

Artificial intelligence (AI) is accelerating progress in modeling T and B cell receptors by enabling predictive and generative frameworks grounded in sequence data and immune context. This chapter surveys recent advances in the use of protein language models, machine learning, and multimodal integration for immune receptor modeling. We highlight emerging strategies to leverage single-cell and repertoire-scale datasets, and optimize immune receptor candidates for therapeutic design. These developments point toward a new generation of data-efficient, generalizable, and clinically relevant models that better capture the diversity and complexity of adaptive immunity.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑